Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Li, Ling ^a   Yang, Chen ^a   Zhao, Yuliang ^a   Zeng, Xiaoxi ^a   Liu, Fang ^a   Fu, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Hyperuricemia; Uric acid

Indexed keywords

URIC ACID;

CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HYPERURICEMIA; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL; BLOOD; FEMALE; MALE; META ANALYSIS; RENAL INSUFFICIENCY, CHRONIC;

COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERURICEMIA; MALE; OBSERVATIONAL STUDY AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84904779112     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-122     Document Type: Review

References (42)

1. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from kidney disease improving global outcomes. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G, Kidney Int 2007 72 247 259
2. Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Tanner RM, Brown TM, Muntner P, Curr Hypertens Rep 2012 14 152 159
3. Chronic kidney disease and diabetes. Pyram R, Kansara A, Banerji MA, Loney-Hutchinson L, Maturitas 2012 71 94 103
4. Identification of patients and risk factors in chronic kidney disease-evaluating risk factors and therapeutic strategies. Levin A, Nephrol Dial Transplant 2001 16 Suppl 7 57 60
5. Hyperuricemia and associated diseases. Becker MA, Jolly M, Rheum Dis Clin North Am 2006 32 275 293 v-vi
6. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, Endou H, Lipkowitz M, Abramson R, Mu W, Johnson RJ, Am J Nephrol 2005 25 425 433
7. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, Nakagawa T, J Am Soc Nephrol 2007 18 2724 2731
8. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. Kang DH, Park SK, Lee IK, Johnson RJ, J Am Soc Nephrol 2005 16 3553 3562
9. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Ford ES, Li C, Cook S, Choi HK, Circulation 2007 115 2526 2532
10. Uric acid and chronic kidney disease: new understanding of an old problem. Kang DH, Chen W, Semin Nephrol 2011 31 447 452
11. Uric acid as a target of therapy in CKD. Jalal DI, Chonchol M, Chen W, Targher G, Am J Kidney Dis 2013 61 134 146
12. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification National Kindey Foundation 2000 http://www.kidney.org/professionals/KDOQI/guideline
13. Wells G, Shea B, O'connell D, Petersen J, Welch V, Losos M, Tugwell P, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Ottawa Health Research Institute http://www.ohri.ca/programs/clinical-epidemiology/oxfordas
14. Green JPHS, Cochrane Handbook for Systematic Reviews of Interventions 2011 http://www.cochrane.org/training/cochrane-handbook
15. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, JAMA 2000 283 2008 2012
16. The association between uric acid and chronic kidney disease in Korean men: a 4-year follow-up study. Ryoo JH, Choi JM, Oh CM, Kim MG, J Korean Med Sci 2013 28 855 860
17. Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan. Chang HY, Lee PH, Lei CC, Tung CW, Hsu YC, Huang TJ, Lu LC, Lin CL, PLoS One 2013 8 61450
18. Serum uric Acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E, Diabetes Care 2012 35 99 104
19. Uric acid levels predict future development of chronic kidney disease. Sonoda H, Takase H, Dohi Y, Kimura G, Am J Nephrol 2011 33 352 357
20. Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study. Kawashima M, Wada K, Ohta H, Terawaki H, Aizawa Y, BMC Nephrol 2011 12 31
21. Serum uric acid and chronic kidney disease: the Severance cohort study. Mok Y, Lee SJ, Kim MS, Cui W, Moon YM, Jee SH, Nephrol Dial Transplant 2012 27 1831 1835
22. Elevated serum uric acid predicts chronic kidney disease. Yamada T, Fukatsu M, Suzuki S, Wada T, Joh T, Am J Med Sci 2011 342 461 466
23. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan. Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L, Nephrology (Carlton) 2011 16 767 776
24. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK, Nephrol Dial Transplant 2010 25 1865 1869
25. Hyperuricemia associated with rapid renal function decline in elderly Taiwanese subjects. Yen CJ, Chiang CK, Ho LC, Hsu SH, Hung KY, Wu KD, Tsai TJ, J Formos Med Assoc 2009 108 921 928
26. Uric acid and incident kidney disease in the community. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, J Am Soc Nephrol 2008 19 1204 1211
27. Predictors of new-onset decline in kidney function in a general middle-european population. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R, Nephrol Dial Transplant 2008 23 1265 1273
28. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, Cheepudomwit S, Yipintsoi T, J Am Soc Nephrol 2005 16 791 799
29. The correlation between uric acid and the incidence and prognosis of kidney diseases: a systematic review and meta-analysis of cohort studies. Li YL, Wang L, Li J, Huang Y, Yuan WM, Zhonghua Nei Ke Za Zhi 2011 50 555 561
30. Uric acid: a surrogate of insulin resistance in older women. Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST, Maturitas 2008 59 55 61
31. Prevalence of chronic kidney disease in Jing adults in China: a village-based study. Xue C, Ye XD, Li W, Peng Q, Ding HY, Zhang YH, He DF, Bai X, Huang Y, Song YS, Pang L, Liao YH, Clin Nephrol 2013 79 50 56
32. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. Feig DI, Soletsky B, Johnson RJ, JAMA 2008 300 924 932
33. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A, Int Urol Nephrol 2007 39 1227 1233
34. Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW, Nephrol Dial Transplant 2014 29 406 413
35. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD, Clin J Am Soc Nephrol 2011 6 2364 2373
36. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Davey Smith G, Lawlor DA, Timpson NJ, BMJ 2013 347 4262
37. Alterations of renal function during dietary-induced hyperuricemia in the rat. Spencer HW, Yarger WE, Robinson RR, Kidney Int 1976 9 489 500
38. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Umekawa T, Chegini N, Khan SR, Nephrol Dial Transplant 2003 18 664 669
39. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ, Am J Physiol Renal Physiol 2002 282 991 F997
40. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB. Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS, Taub M, Am J Physiol Renal Physiol 2007 292 373 F381
41. A role for uric acid in the progression of renal disease. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ, J Am Soc Nephrol 2002 13 2888 2897
42. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH, Am J Physiol Renal Physiol 2013 304 471 F480